Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Transitional Cell × Educational Status × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Neoplasms 4 Fatigue 3 Sleep Wake Disorders 2 Head and Neck Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Initiation and Maintenance Disorders 1 Skin Cancer Prevention 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Postoperative Complications 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Multiple Myeloma 1 Mucositis 1 Melanoma 1 Lymphoma 1 Lymphoid Interstitial Pneumonia 1 Lung Neoplasms 1

Interventions

pembrolizumab 26 atezolizumab 14 Gemcitabine 13 Nivolumab 12 Cisplatin 10 Docetaxel 8 Carboplatin 8 avelumab 7 Mitomycin 7 epacadostat 4 Ipilimumab 4 pemigatinib 3 cabozantinib 3 Paclitaxel 3 Bevacizumab 3 vofatamab 2 rucaparib 2 lenvatinib 2 enfortumab vedotin 2 durvalumab 2 cabazitaxel 2 bempegaldesleukin 2 Standard of Care 2 Specimen Handling 2 Rogaratinib 2 Ramucirumab 2 Radiation 2 Platinum 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡